908 Devices (MASS) Cash from Financing Activities (2020 - 2026)
908 Devices (MASS) reported Cash from Financing Activities of -$2.2 million for Q1 2026, down 1047.09% year-over-year from $228911.7 in Q1 2025, and down 423.67% quarter-over-quarter from -$414000.0 in Q4 2025.
908 Devices (MASS) Cash from Financing Activities (2020 - 2026) Analysis & Trends
908 Devices (MASS) has 7 years of Cash from Financing Activities data on file, last reported at -$2.2 million in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$2.2 million, down 1047.09% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.7 million (down 466.58% YoY), and the FY2025 annual result was -$697000.0, down 85.37% from the prior year.
- Cash from Financing Activities slipped to -$2.2 million in Q1 2026 per MASS's latest filing, from -$414000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $529000.0 in Q4 2024 and troughed at -$15.4 million in Q1 2023.
- A 5-year average of -$1.1 million and a median of -$16000.0 in 2025 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities slumped 11931.54% in 2023, then soared 456.84% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at $411000.0 in 2022, then slumped by 76.89% to $95000.0 in 2023, then soared by 456.84% to $529000.0 in 2024, then slumped by 178.26% to -$414000.0 in 2025, then slumped by 423.67% to -$2.2 million in 2026.
- Business Quant data shows MASS's Cash from Financing Activities at -$2.2 million in Q1 2026, -$414000.0 in Q4 2025, and -$16000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -451.20 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 21.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -25.00 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -97.90 Mn |
| 10 | 908 Devices | 304.12 Mn | 192.38 Mn | 6.88 Mn | -2.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.17 Mn |
| Mar 31, 2026 | -2.17 Mn |
| Dec 31, 2025 | -414,000.00 |
| Dec 31, 2025 | -414,000.00 |
| Sep 30, 2025 | -16,000.00 |
| Sep 30, 2025 | -16,000.00 |
| Jun 30, 2025 | -78,000.00 |
| Jun 30, 2025 | -78,000.00 |
| Mar 31, 2025 | -189,000.00 |
| Mar 31, 2025 | -189,000.00 |
| Dec 31, 2024 | 529,000.00 |
| Dec 31, 2024 | 529,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 367,000.00 |
| Jun 30, 2024 | 367,000.00 |
| Mar 31, 2024 | -1.30 Mn |
| Mar 31, 2024 | -1.30 Mn |
| Dec 31, 2023 | 95,000.00 |
| Dec 31, 2023 | 95,000.00 |